August 2005

Editorial board
Published in issue: August 2005
ii

In this Issue
Published in issue: August 2005
ix

EJC news, issue 12, 2005
Published in issue: August 2005
p1659-1663

Editorial Comment

Is there a future in psychosocial predictive factors in breast cancer?
• Richard Osborne
Published in issue: August 2005
p1665-1666

Position Papers

Adjuvant endocrine therapy in postmenopausal women with early breast cancer: Where are we now?
• M. Baum
Published in issue: August 2005
p1667-1677

The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women
• Henning T. Mouridsen,
• Nicholas J. Robert
Published in issue: August 2005
p1678-1689

Guidelines

REporting recommendations for tumour MARKer prognostic studies (REMARK)
• Lisa M. McShane,
• Douglas G. Altman,
• Willi Sauerbrei,
• ...
• Massimo Gion,
• Gary M. Clark
• for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Published in issue: August 2005
p1690-1696

Review

Health related quality of life outcomes in cancer clinical trials
• A. Bottomley,
• H. Flechtner,
• F. Efficace,
• ...
• J. Blazeby,
• E. Greimel
• On behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Data Center and Quality of Life Group
Published in issue: August 2005
p1697-1709

Clinical Oncology

Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort
• M. Watson,
• Janis Homewood,
• Jo Haviland,
• Judith M. Bliss
Published in issue: August 2005
p1710-1714

Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ
• Lawrence J. Solin,
• Alain Fourquet,
• Frank A. Vicini,
• ...
• Ivo A. Olivotto,
• Nina Bijker,
• Wei-Ting Hwang
Published in issue: August 2005
p1715-1723

Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients
• R.L.M. Haas,
• Ph. Poortmans,
• D. de Jong,
• ...
• M. van der Hulst,
• J.P. de Boer,
• H. Bartelink
Published in issue: August 2005
p1724-1730
Pneumococcal vaccination in splenectomised cancer patients
• Aurelius G. Omlin,
• Kathrin Mühlemann,
• Martin F. Fey,
• Thomas Pabst
Published in issue: August 2005
p1731-1734
Assessment of oral mucositis in clinical trials: Impact of training on evaluators in a multi-centre trial
• M.A. Stokman,
• S.T. Sonis,
• P.U. Dijkstra,
• J.G.M. Burgerhof,
• F.K.L. Spijkervet
Published in issue: August 2005
p1735-1738

Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma
• Catherine Delbaldo,
• Jean-Yves Pierga,
• Véronique Dieras,
• ...
• Arno Nolting,
• Andreas Kovar,
• Eric Raymond
Published in issue: August 2005
p1739-1745

Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-l-carnitine
• Giulia Bianchi,
• Giordano Vitali,
• Augusto Caraceni,
• ...
• Sante Cundari,
• Claudio Zanna,
• Luca Gianni
Published in issue: August 2005
p1746-1750

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg
• John R. Zalcberg,
• Jaap Verweij,
• Paolo G. Casali,
• ...
• Michelle Brown,
• Ian R. Judson
• for the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group and the Australasian Gastrointestinal Trials Group
Published in issue: August 2005
p1751-1757

Paediatric Oncology

Paediatric Update


The role of the specialist nurse in paediatric oncology in the United Kingdom
• Rachel Hollis
Published in issue: August 2005
p1758-1764

Commentary

• Patti Byron
Published in issue: August 2005
p1765-1766

Endocrine late effects from multi-modality treatment of neuroblastoma
• H.M. van Santen,
• J. de Kraker,
• T. Vulsma
Published in issue: August 2005
p1767-1774

Epidemiology and Cancer Prevention

HRT and breast cancer: Impact on population risk and incidence
• Nathan J. Coombs,
• Richard Taylor,
• Nicholas Wilcken,
• John Boyages
Published in issue: August 2005
p1775-1781
Type 2 diabetes mellitus, its treatment and risk for lymphoma
• Joan Fortuny,
• Yolanda Benavente,
• Ramon Bosch,
• Mercedes García-Villanueva,
• Alberto Fernández de Sevilla,
• Sílvia de Sanjosé
Published in issue: August 2005
p1782-1787
Reduction in selective under-ascertainment bias in population-based estimates of cancer patient survival by age adjustment
• Hermann Brenner,
• Timo Hakulinen
Published in issue: August 2005
p1788-1793

Experimental Oncology

Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry
• Julia Diegmann,
• Kerstin Junker,
• Bernhard Gerstmayer,
• ...
• Winfried Hindermann,
• Julia Rosenhahn,
• Ferdinand von Eggeling
Published in issue: August 2005
p1794-1801

Up regulation of ICAM-1 gene expression inhibits tumour growth and liver metastasis in colorectal carcinoma
• Akiko Tachimori,
• Nobuya Yamada,
• Yoji Sakate,
• ...
• Masaichi Ohira,
• Hiroji Nishino,
• Kosei Hirakawa
Published in issue: August 2005
p1802-1810

Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136
• S.M. Guichard,
• J.S. Macpherson,
• D.E. Thurston,
• D.I. Jodrell
Published in issue: August 2005
p1811-1818
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors
• Mirjam M. de Jong,
• Ilja M. Nolte,
• Gerard J. te Meerman,
• ...
• Michael Schaapveld,
• Jan H. Kleibeuker,
• Elisabeth G.E. de Vries
Published in issue: August 2005
p1819-1823

Experimental therapy of human endometrial cancers with a targeted cytotoxic bombesin analog AN-215: Low induction of multidrug resistance proteins
• Jörg B. Engel,
• Andrew V. Schally,
• Gabor Halmos,
• Benjamin Baker,
• Attila Nagy,
• Gunhild Keller
Published in issue: August 2005
p1824-1830

Calendar
Published in issue: August 2005
I-II